Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
18 January, 2022 15:23 IST
Hindustan Unilever gets NCLT's nod for merger with GlaxoSmithKline Consumer Healthcare
Source: IRIS | 27 Feb, 2020, 05.25PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

Hindustan Unilever, one of the leading FMCG firms, said the Chandigarh bench of the National Company Law Tribunal (NCLT) has approved its merger with GlaxoSmithKline Consumer Healthcare.

Earlier, on Sep 24, 2019 the National Company Law Tribunal, Mumbai Bench sanctioned the aforesaid scheme, further it was subject to sanction of scheme by the Chandigarh Bench.

''The effective date of the scheme will be communicated upon being finalized by both companies, in accordance with the procedure,'' said the company in a regulatory filling.

Shares of HUL gained Rs 6.95, or 0.31%, to settle at Rs 2,247.90. The total volume of shares traded was 61,938 at the BSE (Thursday).

 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
ICICI Bank: Leadership position to strengthen; Tech capabilities to drive sustainable growth - 18-Jan-2022 14:36
UltraTech Cement Q3FY22 Review - Outlook positive; Hold - 18-Jan-2022 14:23
VA Tech Wabag secures order worth USD 100 mn in Dubai - 17-Jan-2022 19:43
Glenmark Pharmaceuticals arm gets tentative approval for Regadenoson Injection - 17-Jan-2022 19:16
HDFC Bank Q3FY22 Review-Credit growth improved; Restructured assets at 1.37% vs 1.5% - 17-Jan-2022 17:25
HCL Technologies Q3FY22 Review- Margins to improve gradually - 17-Jan-2022 17:15
HDFC Bank: Earnings in line; Balance Sheet strengthens further - 17-Jan-2022 16:52
Renaissance Global partners with National Football League - 17-Jan-2022 11:26
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer